Sildamax
Sildamax Price range: $ 57,00 through $ 160,00
Back to products
Sildigra Softgel
Sildigra Softgel Price range: $ 42,00 through $ 317,00

Sildigra

Price range: $ 41,00 through $ 369,00

Sildigra is a highly effective medication specifically designed to treat erectile dysfunction and improve male sexual health. Powered by the active ingredient Sildenafil Citrate, it works by increasing blood flow to the pelvic area during natural stimulation. This formula helps men achieve and maintain a firm erection, ensuring a satisfying and confident experience. It is widely recognized for its reliable performance and ability to provide a significant window of physical readiness. By choosing Sildigra, individuals can access a dependable solution for restoring their intimate performance and overall well-being.

Active substance: Sildenafil
SKU: Sildigra Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Sildigra belongs to a pharmacological class of medications known as phosphodiesterase type 5 (PDE5) inhibitors. It contains sildenafil citrate as its active pharmaceutical ingredient and is indicated for the medical management of erectile dysfunction in adult males under proper clinical supervision.

As a formulation containing sildenafil, this drug is evaluated and dispensed in accordance with applicable federal and state regulations within the United States. A formal evaluation by a qualified healthcare provider is necessary to establish individual therapeutic appropriateness and to rule out potential underlying cardiovascular conditions.

Active ingredient Sildenafil citrate
Therapeutic class Phosphodiesterase type 5 (PDE5) inhibitor
Dosage form Oral tablet
Route of administration Oral
Primary purpose Treatment of erectile dysfunction
Prescription status Dispensed in accordance with federal and state regulations

General Overview and Pharmacological Profile

Main uses

Sildigra is primarily prescribed for the treatment of erectile dysfunction (ED), defined as the persistent inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. The active constituent, sildenafil citrate, acts on the vascular smooth muscle of the erectile tissue. In clinical practice, the drug addresses erectile difficulties originating from organic, neurogenic, vasculogenic, or psychogenic etiologies. While sildenafil is also utilized off-label or under alternative proprietary formulations for conditions such as pulmonary arterial hypertension, Sildigra is specifically tailored for male erectile dysfunction. Any off-label application must be explicitly directed and monitored by a licensed physician.

How the drug works

The mechanism of action involves the selective inhibition of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). During sexual arousal, neurovascular stimulation triggers the local release of nitric oxide (NO) from endothelial cells and nerve terminals in the corpus cavernosum of the penis. Nitric oxide activates the enzyme guanylate cyclase, which converts guanosine triphosphate into cyclic GMP. Elevated cGMP levels induce smooth muscle relaxation, arterial dilation, and engorgement of the cavernous tissues. PDE5 enzyme naturally breaks down cGMP, terminating the erection. By inhibiting PDE5, sildenafil prevents cGMP degradation, thereby augmenting the physiological erectile response. Sexual stimulation is an absolute prerequisite for therapeutic effect; the drug does not exert a direct relaxant effect on smooth muscle tissue in the absence of sexual arousal.

What happens in the body

Following oral administration, sildenafil citrate is rapidly absorbed through the gastrointestinal tract. Peak plasma concentration ($C_{max}$) is typically achieved within 30 to 120 minutes, with a median peak time of 60 minutes when taken in a fasted state. The absolute oral bioavailability of the compound is approximately 41%. Sildenafil and its primary circulating active metabolite, N-desmethylsildenafil, are bound to plasma proteins to an extent of approximately 96%. Hepatic metabolism occurs predominantly via the cytochrome P450 enzymatic pathway, utilizing CYP3A4 as the major metabolic route and CYP2C9 as a secondary route. The active N-desmethyl metabolite accounts for roughly 20% of the pharmacological profile of the parent compound, possessing approximately 50% of the parent drug’s PDE5 inhibitory potency. Sildenafil is eliminated primarily as inactive metabolites in the feces (approximately 80% of the administered dose) and to a lesser extent in the urine (approximately 13%). The terminal elimination half-life of sildenafil ranges from 3 to 5 hours.

Dosing schedule

The dosage of Sildigra is individualized by a prescribing physician based on therapeutic response and clinical tolerance. For most adult patients, the standard recommended dose is administered approximately 1 hour prior to intended sexual activity; however, the dose may be taken within a time frame of 30 minutes to 4 hours prior to activity. The maximum recommended dosing frequency is once within a 24-hour period. Dose adjustments are frequently warranted in specific patient populations. Patients older than 65 years, individuals with severe hepatic impairment, or those with severe renal impairment (creatinine clearance less than 30 mL/min) exhibit higher area-under-the-curve (AUC) plasma values and may require a lower initial starting dose to prevent excessive drug accumulation.

If you skip a dose

Because Sildigra is taken strictly on an as-needed basis prior to sexual activity rather than on a continuous, daily dosing schedule, missed doses do not represent a clinical concern. Patients should never double the dose or take supplementary tablets to make up for an omitted or delayed dose. Exceeding the maximum prescribed daily limit significantly elevates the risk of systemic adverse reactions and severe toxicity.

Safety Precautions and Dosing Guidelines

What to avoid while taking it

Certain dietary factors and substances can significantly alter the pharmacokinetics and clinical profile of sildenafil. Co-administration of Sildigra with heavy or high-fat meals delays gastrointestinal absorption, resulting in a delayed peak plasma concentration ($T_{max}$) of approximately one hour and a reduced peak concentration. Alcohol consumption should be minimized or completely avoided during treatment; ethanol acts as a systemic vasodilator and, when combined with sildenafil, increases the risk of orthostatic hypotension, lightheadedness, and impaired erectile performance. Furthermore, ingestion of grapefruit or grapefruit juice inhibits intestinal CYP3A4 enzymes, which can increase systemic exposure to sildenafil and elevate the likelihood of adverse drug events.

What not to combine

Sildigra exhibits severe drug-drug interactions with several therapeutic categories. Co-administration with organic nitrates (such as nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate) or nitric oxide donors (such as amyl nitrite) in any form is strictly contraindicated. Sildenafil potentiates the hypotensive effects of nitrates, which can cause severe, life-threatening drops in systemic blood pressure. Caution is mandatory when combining sildenafil with alpha-adrenergic blockers (such as tamsulosin or doxazosin); concurrent use can lead to symptomatic orthostatic hypotension. Strong CYP3A4 inhibitors, including ketoconazole, itraconazole, erythromycin, and protease inhibitors such as ritonavir, markedly impair sildenafil clearance, necessitating lower initial dosages. Conversely, potent CYP3A4 inducers, such as rifampin, reduce sildenafil plasma concentrations, potentially diminishing efficacy.

Adverse reactions

Side effects associated with sildenafil citrate stem primarily from its systemic vasodilatory action. Common adverse events reported in clinical evaluations include headache, facial flushing, dyspepsia, nasal congestion, back pain, myalgia, and mild dizziness. Transient visual alterations–such as changes in color perception (a blue/green tint to vision), photophobia, or blurred vision–occur in a subset of patients due to weak inhibition of the PDE6 enzyme present in retinal photoreceptors. Most mild side effects are transient and diminish as the medication is metabolized and cleared from systemic circulation.

Red flags

Immediate emergency medical care is required if a patient experiences any of the following severe adverse reactions while using Sildigra:

  • An erection lasting longer than 4 hours (priapism), which can lead to irreversible penile tissue necrosis and permanent erectile impairment if untreated.
  • Sudden monocular or binocular loss of vision, which may be an indicator of non-arteritic anterior ischemic optic neuropathy (NAION).
  • Sudden decrease or total loss of hearing, often accompanied by tinnitus or dizziness.
  • Cardiovascular symptoms such as angina, pressure, shortness of breath, radiating arm pain, or cardiac arrhythmia during or following sexual activity.
  • Severe hypersensitivity reactions, including angioedema (swelling of the face, lips, tongue, or throat), severe rash, or bronchospasm.

Important precautions

Prior to prescribing Sildigra, a thorough cardiovascular risk assessment is essential, as sexual activity carries an inherent cardiac risk for individuals with underlying heart disease. Sildigra should be used with extreme caution in patients with a history of myocardial infarction, stroke, or severe arrhythmia within the preceding 6 months, as well as those with resting hypotension (blood pressure under 90/50 mmHg) or uncontrolled hypertension. Patients with anatomical penile deformities, such as Peyronie’s disease, or those with underlying medical conditions predisposing them to priapism (including sickle cell anemia, multiple myeloma, or leukemia) require careful monitoring. Sildigra is not indicated for use in female patients or pediatric populations.

Storage and expiration

Sildigra tablets should be stored at controlled room temperature, ideally between 68°F and 77°F (20°C to 25°C), with allowed temporary excursions between 59°F and 86°F (15°C to 30°C). The tablets must be kept in their original blister packaging or container to protect the active ingredient from excessive ambient moisture and direct sunlight. Store safely out of the reach of children and domestic pets. Unused or expired medication should not be flushed down household drains; dispose of the drug strictly through certified pharmacy take-back programs in accordance with local regulations.

What should I do if Sildigra does not appear to work?

If Sildigra does not produce an adequate response, do not increase the dosage independently. Therapeutic efficacy depends on multiple factors, including proper timing, presence of sexual stimulation, avoidance of high-fat meals, and underlying health variables. Consult the prescribing healthcare provider to discuss potential dosage adjustments or to investigate underlying vascular or hormonal causes.

Is it safe to drive after taking sildenafil?

Because sildenafil can induce side effects such as dizziness, lightheadedness, or transient visual disturbances (such as altered color perception or blurred vision), patients should observe how they personally react to the medication before driving or operating heavy machinery. If any cognitive or visual impairment occurs, abstain from hazardous tasks until symptoms clear.

Does sildenafil cause an immediate automatic erection?

No, sildenafil does not automatically produce a penile erection upon ingestion. The pharmacological pathway of PDE5 inhibition relies on the natural physiological release of nitric oxide, which occurs only in response to sexual arousal. Without mental or physical sexual stimulation, the medication remains inactive in the corpus cavernosum.

How does food affect the absorption of this medication?

Taking Sildigra alongside or immediately after a high-fat meal can delay gastrointestinal absorption of the active ingredient. While overall bioavailability is not significantly compromised, the onset of therapeutic effect may be delayed by approximately 60 minutes compared to administration in a fasted state.

This text is for informational purposes only and does not constitute individual medical advice. In accordance with FDA requirements.

Additional information
Dosage

25mg

,

50mg

,

100mg

,

120mg

,

130 mg

Package

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία